Talis Biomedical Corporation (NASDAQ: TLIS) Stock Information | RedChip

Talis Biomedical Corporation (NASDAQ: TLIS) Listen to this Section

$4.30
+0.1600 ( +3.87% ) 11.4K

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.

Market Data

Open

$4.30

Previous close

$4.14

Volume

11.4K

Market cap

$7.67M

Day range

$3.99 - $4.31

52 week range

$3.75 - $9.60

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings

Form Type Description Pages Date
10-k Annual reports 73 Mar 28, 2024
8-k 8K-related 10 Jan 26, 2024
10-q Quarterly Reports 55 Nov 14, 2023
8-k 8K-related 13 Nov 14, 2023
8-k 8K-related 12 Sep 01, 2023
10-q Quarterly Reports 52 Aug 10, 2023
8-k 8K-related 33 Aug 10, 2023

Latest News

Terms and Agreement

Please agree to the terms to continue using the chat feature.

About US

Services

Stay Connected